LOW-DOSE-RATE IODINE-125 SEEDS BRACHYTHERAPY: PSA NADIR LESS THAN 1 NG/ML AS PROGNOSTIC FACTOR.

被引：1
|
作者：
Reis, Leonardo O.
Monti, C. R.
Castilho, Lisias N.
Gialluca, V. D.
Reinato, Jose A. S.
Uhmann, E.
Kawakami, N. S.
Ferreira, Ubirajara
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.2087
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2041
引用
收藏
页码：E792 / E793
页数：2
相关论文
共 36 条
  • [11] LOW-DOSE RATE IODINE-125 BRACHYTHERAPY IN RECURRENT MALIGNANT GLIOMAS
    Schwartz, Christoph
    Romagna, Alexander
    Thon, Niklas
    Tonn, Joerg-Christian
    Schwarz, Silke Birgit
    Kreth, Friedrich-Wilhelm
    NEURO-ONCOLOGY, 2013, 15 : 223 - 223
  • [12] Dosiomic predictors of biochemical failure in patients with localized prostate cancer treated with Iodine-125 low-dose-rate brachytherapy
    Masahiro Nakano
    Shizuo Kaji
    Shogo Kawakami
    Hideyasu Tsumura
    Toshikazu Imae
    Yuichi Tanaka
    Kyohei Fujii
    Takuro Kainuma
    Ryosuke Yamazaki
    Ayaka Uchida
    Hijiri Kaneko
    Mako Fujino
    Chizu Hata
    Yu Murakami
    Masatoshi Hashimoto
    Hiromichi Ishiyama
    Radiation Oncology, 20 (1)
  • [13] Re: Placement of SpaceOAR hydrogel spacer for prostate cancer patients treated with iodine-125 low-dose-rate brachytherapy
    Ghaffari, Hamed
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (05) : 473 - 473
  • [14] Low-dose-rate iodine-125 seed air kerma strength measurement intercomparison
    Poder, Joel
    Smith, Ryan
    Haworth, Annette
    BRACHYTHERAPY, 2020, 19 (01) : 119 - 125
  • [15] Editorial Comment to Placement of SpaceOAR hydrogel spacer for prostate cancer patients treated with iodine-125 low-dose-rate brachytherapy
    Tsumura, Hideyasu
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (01) : 66 - 66
  • [16] Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas
    Schwartz, Christoph
    Romagna, Alexander
    Thon, Niklas
    Niyazi, Maximilian
    Watson, Juliana
    Belka, Claus
    Tonn, Joerg-Christian
    Kreth, Friedrich-Wilhelm
    Nachbichler, Silke Birgit
    ACTA NEUROCHIRURGICA, 2015, 157 (10) : 1757 - 1764
  • [17] Clinical outcomes of iodine-125 low-dose-rate brachytherapy for localized prostate cancer: a single-institution review in Japan
    Nakiri, Makoto
    Ogasawara, Naoyuki
    Kurose, Hirofumi
    Ueda, Kosuke
    Chikui, Katsuaki
    Nishihara, Kiyoaki
    Ejima, Kazuhisa
    Uemura, Keiichiro
    Murotani, Kenta
    Muraki, Koichiro
    Hattori, Chikayuki
    Ogo, Etsuyo
    Morimatsu, Yoshitaka
    Ishitake, Tatsuya
    Igawa, Tsukasa
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2022, 14 (02) : 157 - 168
  • [18] Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas
    Christoph Schwartz
    Alexander Romagna
    Niklas Thon
    Maximilian Niyazi
    Juliana Watson
    Claus Belka
    Jörg-Christian Tonn
    Friedrich-Wilhelm Kreth
    Silke Birgit Nachbichler
    Acta Neurochirurgica, 2015, 157 : 1757 - 1764
  • [19] Enhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy
    Kubo, Makoto
    Satoh, Takefumi
    Ishiyama, Hiromichi
    Tabata, Ken-Ichi
    Tsumura, Hideyasu
    Komori, Shoko
    Iwamura, Masatsugu
    Baba, Shiro
    Hayakawa, Kazushige
    Kawamura, Toshihiko
    Obata, Fumiya
    ONCOLOGY REPORTS, 2018, 39 (01) : 417 - 424
  • [20] A machine-learning approach based on 409 treatments to predict optimal number of iodine-125 seeds in low-dose-rate prostate
    Boussion, Nicolas
    Schick, Ulrike
    Dissaux, Gurvan
    Ollivier, Luc
    Goasduff, Gaelle
    Pradier, Olivier
    Valeri, Antoine
    Visvikis, Dimitris
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2021, 13 (05) : 541 - 548
1234